Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Khadidja,Abdallah

第一单位： Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Onderwijs en Navorsing 2 bus 521, Herestraat 49, 3000, Leuven, Belgium. kha.abdallah@hotmail.com.

作者： Khadidja,Abdallah ^[1] ; Isabelle,Huys ^[2] ; Kathleen J,Claes ^[3] ; Steven,Simoens ^[2]

作者单位： Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Onderwijs en Navorsing 2 bus 521, Herestraat 49, 3000, Leuven, Belgium. kha.abdallah@hotmail.com. ^[1] Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Onderwijs en Navorsing 2 bus 521, Herestraat 49, 3000, Leuven, Belgium. ^[2] Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.;Department of Nephrology and Renal Transplantation, UZ Leuven, Leuven, Belgium. ^[3]

主题词人类(Humans);贫血, 镰状细胞性(Anemia, Sickle Cell);预算(Budgets);比利时(Belgium);费用效益分析(Cost-Benefit Analysis)

DOI 10.1007/s40261-024-01384-w

PMID 39134876

发布时间 2024-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交